Repligen Co. (NASDAQ:RGEN – Get Free Report)’s stock price traded up 4.6% during trading on Thursday . The company traded as high as $150.43 and last traded at $149.09. 156,091 shares traded hands during trading, a decline of 72% from the average session volume of 561,980 shares. The stock had previously closed at $142.51. Wall […]
Oregon Public Employees Retirement Fund reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 0.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 15,007 shares of the biotechnology company’s stock after selling 131 shares during the period. Oregon Public Employees Retirement Fund’s holdings […]
Teacher Retirement System of Texas cut its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 31.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,997 shares of the biotechnology company’s stock after selling 1,870 shares during the quarter. Teacher Retirement […]
Virtu Financial LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 16.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,574 shares of the biotechnology company’s stock after buying an additional 794 shares during the period. […]
Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine ratings firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 […]